Therapy News and Research

RSS

New, potential treatment combination for patients with aggressive head and neck cancer

The current treatment of patients diagnosed with advanced or metastatic head and neck cancer (HNC) is ineffective.

28 Mar 2022

Depression occurs independently of inflammation for many older people, study suggests

Multiple prior studies have found higher levels of inflammation in older individuals with depression. Now, a new Penn Medicine study has found that clinically depressed older individuals, on average, don't have elevated levels of inflammation if they don't already have other inflammatory conditions such as arthritis.

28 Mar 2022

A cluster of cells in the brainstem found to control the body's response to severe blood loss

University of Virginia School of Medicine scientists have discovered a cluster of cells in the brainstem that controls the body's response to severe blood loss, a finding which could benefit efforts to develop new treatments for traumatic injuries.

28 Mar 2022

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

In this interview, we speak to Kirill Kiselyov, Ph.D, and Umamaheswar Duvvuri, M.D, Ph.D, from the University of Pittsburgh, about their latest research into hydroxychloroquine, a drug widely used to prevent and treat malaria, as a potential treatment for head and neck cancers.

28 Mar 2022

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

The first year of the COVID-19 pandemic saw fewer hospital visits for stroke, fewer stroke therapies, more treatment delays and a higher risk of in-hospital deaths in the subsequent COVID-19 waves, according to an Alberta study published in CMAJ.

28 Mar 2022

Clinical determinants of post-COVID-19 thromboembolism

Researchers quantify the risk of acute VTE due to SARS-CoV-2 infection in ambulatory settings.

27 Mar 2022

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that people living with HIV who are on antiretroviral treatment (ART) with protease inhibitors (PI), may have a lower risk of COVID-19 infection.

27 Mar 2022

Exercise elicits benefits to breast cancer patients’ physical and mental health

Exercise helps breast cancer patients with the physical and mental side effects of treatment, a new Loughborough University study has found, and ultimately it may improve disease prognosis.

25 Mar 2022

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

A new study has focussed on conducting a systematic search of the literature and aggregated data associated with randomized control trials of passive antibody therapy.

25 Mar 2022

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

25 Mar 2022

Impact of truncated open reading frame 8 protein variants of SARS-CoV-2

A new study identified unique truncated open reading frame 8 proteins among SARS-CoV-2 sequences.

25 Mar 2022

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Antithrombotic therapy is prescribed to prevent thrombotic (blood clotting inside a blood vessel) events but the treatment also increases the likelihood of experiencing a bleeding event, which can be extremely serious if it occurs in a vital organ.

25 Mar 2022

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis.

24 Mar 2022

Spinal fluid sampling could provide data about tumors sooner than MRIs

Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response.

24 Mar 2022

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Parkinsonism is a term for a group of neurological conditions that cause movement problems including tremors, slowed movement and stiffness, with Parkinson's disease being one of the better knowns causes.

24 Mar 2022

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate COVID-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.

24 Mar 2022

Short duration treatment effective in combating most childhood TB cases, study says

Short duration treatment — four months instead of the standard six — is as effective in combating most cases of childhood tuberculosis (TB), says a study carried out in India and some African countries.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Just as a water filtration system acts to filter contaminants from the water you drink, your kidneys act to filter waste and excess fluid from your blood.

24 Mar 2022

Study uncovers a gene that strongly associates with breast cancer patient's treatment outcomes

A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies.

23 Mar 2022

Therapy News and Research

New, potential treatment combination for patients with aggressive head and neck cancer

Depression occurs independently of inflammation for many older people, study suggests

A cluster of cells in the brainstem found to control the body's response to severe blood loss

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

Clinical determinants of post-COVID-19 thromboembolism

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

Exercise elicits benefits to breast cancer patients’ physical and mental health

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Impact of truncated open reading frame 8 protein variants of SARS-CoV-2

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Spinal fluid sampling could provide data about tumors sooner than MRIs

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

Short duration treatment effective in combating most childhood TB cases, study says

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Study uncovers a gene that strongly associates with breast cancer patient's treatment outcomes

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News